Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Intrinsic Value
The intrinsic value of one DAWN stock under the Base Case scenario is hidden USD. Compared to the current market price of 6.73 USD, Day One Biopharmaceuticals Inc is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Day One Biopharmaceuticals Inc
DAWN looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if DAWN is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Fundamental Analysis

Revenue & Expenses Breakdown
Day One Biopharmaceuticals Inc
Balance Sheet Decomposition
Day One Biopharmaceuticals Inc
Current Assets | 508.7m |
Cash & Short-Term Investments | 473m |
Receivables | 18.1m |
Other Current Assets | 17.6m |
Non-Current Assets | 25.7m |
Long-Term Investments | 215k |
PP&E | 5.1m |
Intangibles | 20.4m |
Free Cash Flow Analysis
Day One Biopharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Day One Biopharmaceuticals Inc
Revenue
|
161.9m
USD
|
Cost of Revenue
|
-8.2m
USD
|
Gross Profit
|
153.8m
USD
|
Operating Expenses
|
-237.3m
USD
|
Operating Income
|
-83.6m
USD
|
Other Expenses
|
14.5m
USD
|
Net Income
|
-69.1m
USD
|
DAWN Profitability Score
Profitability Due Diligence
Day One Biopharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Day One Biopharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
DAWN Solvency Score
Solvency Due Diligence
Day One Biopharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Day One Biopharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DAWN Price Targets Summary
Day One Biopharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for DAWN is 28.41 USD with a low forecast of 20.2 USD and a high forecast of 37.8 USD.
Dividends
Current shareholder yield for DAWN is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one DAWN stock under the Base Case scenario is hidden USD.
Compared to the current market price of 6.73 USD, Day One Biopharmaceuticals Inc is hidden .